Karin Anderson
Adult Health · Columbus, OHNPI 1871862359
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.3% of the total across 305 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by Viiv Healthcare Company at 33.0% of the total. Among adult health clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 305 payments — averaging $26.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$3K
- Gilead$2K
- Lilly USA, LLC$593
- Janssen Products, LP$340
- AbbVie$327
- Napo Pharmaceuticals Inc$308
- plus $2K from 17 others
What the payments were for
- Food & beverage$8,11899%
- Education$571%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 95 | $2,696 |
| Gilead | 80 | $2,332 |
| Lilly USA, LLC | 19 | $593 |
| Janssen Products, LP | 4 | $340 |
| AbbVie | 18 | $327 |
| Napo Pharmaceuticals Inc | 15 | $308 |
| Merck | 11 | $284 |
| Johnson & Johnson(2 entities) | 16 | $255 |
| Theratechnologies Inc. | 7 | $143 |
| Novo Nordisk | 8 | $136 |
| Exact Sciences | 5 | $121 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $112 |
| EMD Serono, Inc. | 3 | $85 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $82 |
| Organon | 1 | $78 |
| Otsuka America Pharmaceutical, Inc. | 4 | $72 |
| Axsome Therapeutics, Inc. | 3 | $54 |
| Verity Pharmaceuticals Inc. | 2 | $47 |
| Boehringer Ingelheim | 1 | $27 |
| Antares Pharma, Inc. | 1 | $23 |
| Corcept Therapeutics | 1 | $23 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,175 in reported general payments places this provider in the 95th percentile of 1,184 adult health providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 60 | $238,259 |
| DovatoDolutegravir Sodium/Lamivudine | 21 | $62,075 |
| OzempicSemaglutide | 29 | $24,867 |
| JardianceEmpagliflozin | 14 | $6,694 |
| Olmesartan-Amlodipine-HctzOlmesartan/Amlodipin/Hcthiazid | 18 | $1,030 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 12 | $341 |
| Gabapentin | 28 | $246 |
| Fluticasone Propionate | 17 | $210 |
| Atorvastatin Calcium | 53 | $199 |
| ClopidogrelClopidogrel Bisulfate | 11 | $97 |
| Montelukast Sodium | 18 | $89 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 13 | $67 |
| Cyclobenzaprine Hcl | 17 | $62 |
| Escitalopram Oxalate | 16 | $55 |
| Methocarbamol | 13 | $53 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadBiktarvy | $2,332 | $238,25960 claims |
| Viiv Healthcare CompanyDovato | $2,696 | $62,07521 claims |
| Novo NordiskOzempic | $136 | $24,86729 claims |
| Boehringer IngelheimJardiance | $27 | $6,69414 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,184 adult health providers in Ohio.
Other adult health in Columbus
- Lucretia LongColumbus$76K
- Marybeth RivardColumbus$41K
- Constance Nicastro-BowmanColumbus$28K
- Michelle MormileColumbus$22K
- Kathleen MooreColumbus$17K
- Laura PopelarColumbus$17K
- James BetzColumbus$15K
- Mollie MoranColumbus$11K
- Jennifer ObrienColumbus$9K
- Megan JosephColumbus$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.